[Oliguria and rise in creatine phosphokinase as a side-effect of citalopram]
- PMID: 15207203
- PMCID: PMC7688698
- DOI: 10.1016/s0212-6567(04)79454-8
[Oliguria and rise in creatine phosphokinase as a side-effect of citalopram]
Similar articles
-
Unfavorable smell with citalopram?J Clin Psychopharmacol. 2007 Oct;27(5):528-9. doi: 10.1097/JCP.0b013e3181520751. J Clin Psychopharmacol. 2007. PMID: 17873697 No abstract available.
-
Behavioral disinhibition without persistent mood elevation after high dose citalopram treatment.Braz J Psychiatry. 2007 Dec;29(4):384-5. doi: 10.1590/s1516-44462007000400022. Braz J Psychiatry. 2007. PMID: 18200405 No abstract available.
-
First time, low dose citalopram use-related serotonin syndrome.Neurotoxicology. 2007 Nov;28(6):1272-4. doi: 10.1016/j.neuro.2007.05.004. Neurotoxicology. 2007. PMID: 18213744
-
[The inappropriate antidiuretic hormone secretion syndrome and citalopram].Med Clin (Barc). 1999 Jan 23;112(2):78. Med Clin (Barc). 1999. PMID: 10065438 Review. Spanish. No abstract available.
-
Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?Am J Med. 2012 Sep;125(9):859-68. doi: 10.1016/j.amjmed.2011.12.002. Epub 2012 Jun 27. Am J Med. 2012. PMID: 22748401 Review.
References
-
- Jonasson B., Saldeen T. Citalopram in fatal poisoning cases. Forensic Sci Int. 2002;126:1–6. - PubMed
-
- Zullino D., Brauchli S., Horvath A., Baumann P. Inapropiate antidiuretic hormone secretion and rhabdomyolysis associated with citalopram. Therapie. 2000;55:651–652. - PubMed
-
- Citalopram. AntidepressantsFacts 2003 [consultado 1/08/72003]. Disponible http://www.antidepressantsfacts.com/celexa.htm
-
- Aydin N, Anaç E, Çaykôylü A, Akçay F. Neuroleptic malignant syndrome due to citalopram overdose [carta]. Can J PsyÂchiatry 2000;45:941-2. Disponible http://www.cpa-apc.org/Publications/Archives/CJP/2000/Dec/Letters6.asp - PubMed
-
- Other events observed during the postÂmarketing evaluation of celexa (citalopram HBr). The FDA Safety Information and Adverse Event Reporting Program. 2002 Nov [consultado el 01/08/2003]: DispoÂnible http://www.fda.gov/medwatch/SA-FETY/2002/nov02.htm
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources